ocrelizumab monoclonal antibody drug. targets cd20 on b-cells and is used in the treatment multiple sclerosis. generic name and.

antibody anticd20 bcell biological biosimilar biotech biotechnology blymphocyte cd20 disease drug immunoglobulin immunology immunosuppression immunosuppressive infusion injection inn mab monoclonal multiple nomenclature ocrelizumab peptide protein sclerosis